MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kocarek, T. A.
Right arrow Articles by Guzelian, P. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kocarek, T. A.
Right arrow Articles by Guzelian, P. S.

Selective induction of cytochrome P450e by kepone (chlordecone) in primary cultures of adult rat hepatocytes

TA Kocarek, EG Schuetz and PS Guzelian

Department of Medicine, Medical College of Virginia, Richmond 23298.

Cytochromes P450b and P450e (IIB1 and IIB2, respectively) are two remarkably similar microsomal hemoproteins whose inductions in rat liver are generally believed to be coordinately controlled by such xenobiotics as phenobarbital. To critically examine this assumption, we used a new system of primary cultures of adult rat hepatocytes on Matrigel to evaluate whether organochlorine pesticides, as "phenobarbital-like" agents, directly induce these cytochromes in parallel in the liver parenchymal cell. For 14 of the pesticides we tested, as well as for phenobarbital, P450b and P450e mRNAs, measured on Northern blots, rose in concert as much as 58- and 6-fold, respectively, over the amounts in incubated control cultures. Kepone (chlordecone) treatment of the cultures increased P450e mRNA in a dose- dependent manner that disclosed a 10-fold greater potency, compared with cultures exposed to phenobarbital. Kepone also resembled phenobarbital in these experiments, in that there were dose-dependent increases in the amounts of hepatocellular P450p, P450pcn2, P450PB-1, P450f, and NADPH-cytochrome P450 oxidoreductase mRNAs. However, in the same kepone-treated cells, P450b mRNA or P450b immunoreactive protein was induced only slightly, if at all. In contrast, additions to the medium of mirex, a structural analog of kepone, effectively induced both P450b and P450e mRNAs and their proteins. Selective induction of P450e by kepone in the hepatocyte cultures, the first pharmacologic dissociation of the induction of P450b and P450e mRNAs and proteins, was not apparent in kepone-treated rats, where both P450b and P450e mRNAs were increased to equivalent extents. We conclude that the P450b and P450e genes may be expressed independently by process(es), possibly involving extrahepatic factors, that can be defined with the present hepatocyte culture system.

Volume 40, Issue 2, pp. 203-210, 08/01/1991
Copyright © 1991 by American Society for Pharmacology and Experimental Therapeutics







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1991 by the American Society for Pharmacology and Experimental Therapeutics